Similar articles for PMID: 11020235

Year	Number of Results
1969	2
1971	1
1974	1
1975	1
1977	2
1979	1
1980	5
1981	2
1982	3
1983	4
1984	7
1985	4
1986	3
1987	4
1988	2
1989	3
1990	5
1991	5
1992	2
1993	6
1994	9
1995	8
1996	13
1997	20
1998	20
1999	10
2000	23
2001	18
2002	14
2003	18
2004	17
2005	15
2006	9
2007	9
2008	15
2009	9
2010	9
2011	11
2012	13
2013	13
2014	9
2015	11
2016	9
2017	11
2018	7
2019	5
2020	7
2021	7
2022	5
2023	2
2024	0

1

Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.

Shen J, Benedict Gomes A, Gallagher A, Stafford K, Yoburn BC. Shen J, et al. Synapse. 2000 Dec 1;38(3):322-7. doi: 10.1002/1098-2396(20001201)38:3<322::AID-SYN11>3.0.CO;2-1. Synapse. 2000. PMID: 11020235

2

Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.

Yoburn BC, Gomes BA, Rajashekara V, Patel C, Patel M. Yoburn BC, et al. Synapse. 2003 Feb;47(2):109-16. doi: 10.1002/syn.10149. Synapse. 2003. PMID: 12454948

3

In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.

Duttaroy A, Yoburn BC. Duttaroy A, et al. Synapse. 2000 Aug;37(2):118-24. doi: 10.1002/1098-2396(200008)37:2<118::AID-SYN6>3.0.CO;2-2. Synapse. 2000. PMID: 10881033

4

Opioid receptor regulation in mice.

Yoburn BC, Billings B, Duttaroy A. Yoburn BC, et al. J Pharmacol Exp Ther. 1993 Apr;265(1):314-20. J Pharmacol Exp Ther. 1993. PMID: 8386239

5

Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.

Yoburn BC, Purohit V, Patel K, Zhang Q. Yoburn BC, et al. Eur J Pharmacol. 2004 Sep 13;498(1-3):87-96. doi: 10.1016/j.ejphar.2004.07.052. Eur J Pharmacol. 2004. PMID: 15363980

6

mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.

Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T. Narita M, et al. Neuroscience. 2006;138(2):609-19. doi: 10.1016/j.neuroscience.2005.11.046. Epub 2006 Jan 18. Neuroscience. 2006. PMID: 16417975

7

Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.

Xu H, Wang X, Wang J, Rothman RB. Xu H, et al. Synapse. 2004 Jun 1;52(3):209-17. doi: 10.1002/syn.20019. Synapse. 2004. PMID: 15065220

8

Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.

Wagner EJ, Rønnekleiv OK, Kelly MJ. Wagner EJ, et al. J Pharmacol Exp Ther. 1998 Jun;285(3):1266-73. J Pharmacol Exp Ther. 1998. PMID: 9618432

9

Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.

Pawar M, Kumar P, Sunkaraneni S, Sirohi S, Walker EA, Yoburn BC. Pawar M, et al. Eur J Pharmacol. 2007 Jun 1;563(1-3):92-101. doi: 10.1016/j.ejphar.2007.01.059. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17349996 Free PMC article.

10

mu-Opioid receptor downregulation contributes to opioid tolerance in vivo.

Stafford K, Gomes AB, Shen J, Yoburn BC. Stafford K, et al. Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):233-7. doi: 10.1016/s0091-3057(01)00525-1. Pharmacol Biochem Behav. 2001. PMID: 11420091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

382 results

Results by year